Stay updated on Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now presents the ClinicalTrials.gov record for a Phase 1b galidesivir study in hospitalized adults with yellow fever or COVID-19, including its study design, participant criteria, locations, and measured outcomes. The record indicates the trial was terminated and is no longer recruiting.
    Difference
    50%
    Check dated 2026-11-08T13:36:02.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page otherwise continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:50:30.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” in its content.
    Difference
    1%
    Check dated 2026-10-25T14:00:26.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:33:14.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:14:57.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record details, indicating access is blocked and the content is not retrievable at this time.
    Difference
    18%
    Check dated 2026-09-20T19:57:31.000Z thumbnail image

Stay in the know with updates to Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.